The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (16.92) USD. With the latest stock price at 1.03 USD, the upside of Cytosorbents Corp based on DCF is -1743.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 8.6% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (65.00) - (10.04) | (16.92) |
| Upside | -6410.5% - -1075.0% | -1743.1% |